Pediatric Oncology
Pediatric Oncology
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
59
Clinical Trials
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT04301843 / BCC015
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma.
Learn More
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT04696029 / BCC016
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Learn More
Pediatric Oncology
Phase I/II
Enrolling
nct/study# NCT06541262 / BCC021
Phase I/II study of Silmitasertib (CX-4945) in combination withchemotherapy in children and young adults with relapsed refractory solid tumors
Learn More
Pediatric Oncology
N/A
Enrolling
nct/study# NCT05448560 / BRIDGES
BRidging Information Divides and Gaps for Equity in Survivorship (BRIDGES)
Learn More
Pediatric Oncology
N/A
Enrolling
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT02981628 / COG-AALL1621
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.